F-star acquires new leadership team to pursue home-grown opportunities in UK
This article was originally published in Scrip
Executive Summary
F-star, a next generation antibody platform company, has hired a new management team to oversee the company's pursuit of internal bispecific antibody programmes, establishment of an additional corporate partnership, while shifting the company's research centre gravity westward to the UK.